Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

The Pediatric AIDS Severity Score (PASS): A multidimensional AIDS-severity adjustment for pediatric HIV infection

Article Abstract:

A study developed pediatric AIDS severity score (PASS) by using baseline sociodemographic clinical, immunologic and functional measures obtained from 786 perinatally HIV-infected children enrolled into a prospective cohort (PACTG 219) study in the pre-highly active antiretroviral therapy (HAART) era. It is concluded that PASS would be helpful in assessing the effectiveness of ART among children with HIV infection, particularly when randomized clinical trials are not possible due to ethical and feasibility concerns.

Author: Seage, George R.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
HIV infection in children, Pediatric HIV infections, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Simple Pediatric Aids Severity Score (PASS): A pediatric severity Score for resource-limited settings

Article Abstract:

A study developed multidimensional pediatric AIDS severity score (PASS) for severity adjustment and as a predictive model for mortality in a pediatric HIV-infected population. It is seen that the Simple PASS scoring system presents a reasonable alternative to CD4% values and HIV viral-load levels to assess prognosis and guide decisions about antiretroviral therapy initiation in resource-limited settings.

Author: Seage, George R., Weinberg, Geoffrey A., Patel, Kunjal
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
Prognosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The Chilean AIDS cohort: A model for evaluating the impact of an expanded access program to antiretroviral therapy in a middle-income country-organization and preliminary results

Article Abstract:

A study was conducted in Chile, a middle-income country to evaluate the impact of expanded access program (EAP) to antiretroviral therapy (ART). The report derived from the Chilean EAP and its evaluated impact would be useful to countries with similar economic capacity, epidemic status as the Chilean AIDS Cohort (ChiAC) with its preliminary results.

Author: Wolff, Marcelo J., Beltran, Carlos J., Vasquez, Partricia, Ayala, Marisol X., Valenzuela, Miguel, Berrios, Gloria, Arredondo, Anabella
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
Chile

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Health aspects, Drug therapy, Antiviral agents, Antiretroviral agents, AIDS (Disease)
Similar abstracts:
  • Abstracts: The role of vertical transmission and health care-related factors in HIV infection of children. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C
  • Abstracts: Protective factors may prevent alcoholism. Routine male circumcision could prevent millions of HIV infections in Africa
  • Abstracts: The obstetrician-gynecologist's role in the practical management of polycystic ovary syndrome. Ovarian interstitial YAG-laser: An effective new method to manage anovulation in women with polycystic ovary syndrome
  • Abstracts: DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. A new algorithm weighs in
  • Abstracts: Prevention of malaria in long-term travelers. Controversies and misconceptions in malaria chemoprophylaxis for travelers
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.